7182028/Beijing Natural Science Foundation[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2021	1
2022	3
2025	0

Page 1

Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinoma.

Wang H, Zhu X, Zhao Y, Dong D, Li L, Cai Y, Li Y, Wang W. Wang H, et al. BMC Cancer. 2022 Jul 15;22(1):771. doi: 10.1186/s12885-022-09819-3. BMC Cancer. 2022. PMID: 35840914 Free PMC article. Clinical Trial.

Stereotactic body radiotherapy prolongs the progression-free survival and delays the change of systemic therapy regimen in patients with lung oligoprogressive metastatic colorectal cancer.

Li S, Dong D, Geng J, Zhu X, Shi C, Zhang Y, Wang H, Zhou S, Wu H, Cai Y, Li Y, Wang W. Li S, et al. Asia Pac J Clin Oncol. 2022 Apr;18(2):e64-e72. doi: 10.1111/ajco.13557. Epub 2021 Feb 25. Asia Pac J Clin Oncol. 2022. PMID: 33629479

Dentate line invasion as a predictive factor of poor distant relapse-free survival in locally advanced lower rectal cancer with anal sphincter involvement.

Song M, Wang H, Wang L, Li S, Zhang Y, Geng J, Zhu X, Li Y, Cai Y, Wang W. Song M, et al. BMC Cancer. 2022 Nov 19;22(1):1196. doi: 10.1186/s12885-022-10299-8. BMC Cancer. 2022. PMID: 36403007 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year